A Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With Eltrombopag
Clinical trial NCT07587723 · RECRUITING
Trial details
- NCT number
- NCT07587723
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-06-25
- Primary completion
- 2028-09-29
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.